Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...
ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient access ...
GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, said Wednesday it is launching a new program intended to increase access to exome sequencing for pediatric epilepsy patients.
Please provide your email address to receive an email when new articles are posted on . The model expedites access to specialists after a first seizure. The mean time between the referral and the ...
NeuLine Health (844-212-5321) launches its mobile electroencephalogram (EEG) testing program for residents in Atlanta. McKinney, United States - December 1, 2023 — The new ambulatory EEG bridges the ...
A new tool could potentially reduce epilepsy misdiagnoses by up to 70%, new research suggests. Known as EpiScalp, the tool uses algorithms trained on dynamic network models to map brainwave patterns ...
Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...
AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback